Statistical challenges for central monitoring in clinical trials: a review.

about

Barriers to the conduct of randomised clinical trials within all disease areas.The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017).

P2860

Q38369293-8C1EA1CA-40A8-4E04-BEA9-227866B5DDCD Q47161072-28463F5F-7010-4283-A596-572F97559B81

P2860

Statistical challenges for central monitoring in clinical trials: a review.

Item

http://www.wikidata.org/entity/Q38615977

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Statistical challenges for central monitoring in clinical trials: a review.

@en

type

Item

label

Statistical challenges for central monitoring in clinical trials: a review.

@en

prefLabel

Statistical challenges for central monitoring in clinical trials: a review.

@en

P1476

Statistical challenges for central monitoring in clinical trials: a review

@en

P2093

Koji Oba

http://www.w3.org/2001/XMLSchema#string

P2860

Central and statistical data monitoring in the Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage (CRASH-2) trial.

Statistical monitoring of data quality and consistency in the Stomach Cancer Adjuvant Multi-institutional Trial Group Trial.

Are these data real? Statistical methods for the detection of data fabrication in clinical trials.

Ensuring trial validity by data quality assurance and diversification of monitoring methods.

A statistical approach to central monitoring of data quality in clinical trials.

Central site monitoring: results from a test of accuracy in identifying trials and sites failing Food and Drug Administration inspection.

Summarizing the incidence of adverse events using volcano plots and time intervals.

Application of methods for central statistical monitoring in clinical trials.

Validation of a risk-assessment scale and a risk-adapted monitoring plan for academic clinical research studies--the Pre-Optimon study.

The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials.

P2888

s10147-015-0914-4

P304

28-37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10147-015-0914-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Koji Oba

P577

2015-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26499195

http://www.w3.org/2001/XMLSchema#string

P921

Amar

Statistical challenges for central monitoring in clinical trials: a review.

about

P2860

P2860

Statistical challenges for central monitoring in clinical trials: a review.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921